全文获取类型
收费全文 | 29169篇 |
免费 | 3423篇 |
国内免费 | 925篇 |
专业分类
耳鼻咽喉 | 196篇 |
儿科学 | 759篇 |
妇产科学 | 620篇 |
基础医学 | 4926篇 |
口腔科学 | 415篇 |
临床医学 | 3107篇 |
内科学 | 4345篇 |
皮肤病学 | 514篇 |
神经病学 | 1325篇 |
特种医学 | 1177篇 |
外国民族医学 | 4篇 |
外科学 | 4175篇 |
综合类 | 4110篇 |
一般理论 | 3篇 |
预防医学 | 1912篇 |
眼科学 | 367篇 |
药学 | 2431篇 |
14篇 | |
中国医学 | 1438篇 |
肿瘤学 | 1679篇 |
出版年
2024年 | 30篇 |
2023年 | 782篇 |
2022年 | 771篇 |
2021年 | 1696篇 |
2020年 | 1561篇 |
2019年 | 1401篇 |
2018年 | 1200篇 |
2017年 | 1407篇 |
2016年 | 1255篇 |
2015年 | 1154篇 |
2014年 | 1687篇 |
2013年 | 2249篇 |
2012年 | 1478篇 |
2011年 | 1605篇 |
2010年 | 1340篇 |
2009年 | 1274篇 |
2008年 | 1181篇 |
2007年 | 1229篇 |
2006年 | 1162篇 |
2005年 | 989篇 |
2004年 | 887篇 |
2003年 | 780篇 |
2002年 | 691篇 |
2001年 | 650篇 |
2000年 | 510篇 |
1999年 | 459篇 |
1998年 | 388篇 |
1997年 | 319篇 |
1996年 | 325篇 |
1995年 | 337篇 |
1994年 | 296篇 |
1993年 | 222篇 |
1992年 | 213篇 |
1991年 | 247篇 |
1990年 | 168篇 |
1989年 | 143篇 |
1988年 | 157篇 |
1987年 | 174篇 |
1986年 | 140篇 |
1985年 | 192篇 |
1984年 | 164篇 |
1983年 | 104篇 |
1982年 | 135篇 |
1981年 | 80篇 |
1980年 | 73篇 |
1979年 | 54篇 |
1978年 | 47篇 |
1977年 | 32篇 |
1976年 | 38篇 |
1973年 | 15篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《Revista brasileira de otorrinolaringologia (English ed.)》2022,88(4):621-624
ObjectivesRecurrent Aphthous Stomatitis (RAS) a chronic idiopathic oral mucosal disease. But yet the etiology and pathogenesis of RAS are not exactly known, it is thought that inflammation play an important role in the pathogenesis. The aim of this study is to demonstrate the role of systemic inflammation among the possible etiological factors of RAS and to find the possible diagnostic correlation between Systemic Immune Inflammation Index (SII).MethodsPatients who were consulted the otolaryngology outpatient clinic and diagnosed with RAS between 2019–2021 were retrospectively analyzed. Neutrophil/Lymphocyte Ratio (NLR), Platelet/Lymphocyte Ratio (PLR) and SII values were calculated based on the results of complete blood count. Demographic and hematological parameters between control and RAS groups were compared. The statistical significance level was considered as <0.05.ResultsThere was no statistically significant difference between the control and RAS groups in terms of sex and age distributions (p = 0.566 and p = 0.173, respectively). SII, NLR and PLR values were significantly higher in the RAS group compared to the controls (p < 0.001, p < 0.001 and p = 0.001, respectively). A very strong correlation between SII and NLR, moderately strong correlation between SII and PLR and moderate correlation between NLR and PLR values were detected (respectively ρ: 0.813, 0.719, 0.532; p-values <0.001).ConclusionSII, NLR and PLR has significantly higher levels in the RAS group compared to the control group, that it supports the role of systemic inflammation in the etiopathogenesis of RAS. In addition, the results show that SII is a valuable marker for inflammation.Level of evidence4. 相似文献
2.
3.
4.
目的 研究社区获得性肺炎(community acquired pneumonia,CAP)患儿血清维生素A(vitamin A,VA)水平及与免疫功能的相关性,为肺炎病情评估提供一定参考。方法 以入住新乡医学院第一附属医院PICU的63例重度社区获得性肺炎(severe community acquired pneumonia, SCAP)患儿(SCAP组)、普通儿科病区的30例轻度社区获得性肺炎(mild community acquired pneumonia, MCAP)患儿(MCAP组),以及同期体检的30名健康儿童(对照组)为研究对象,检测其血清中VA和免疫球蛋白(immunoglobulin,Ig)G、IgA、IgM水平,及SCAP组体内T淋巴细胞亚群(总T淋巴细胞、CD4、CD8、CD4/CD8),并对SCAP组体内VA水平及以上指标的相关性进行分析。结果 3组性别和年龄差异无统计学意义;血清中VA的平均含量分别为0.36、0.25和0.19 mg/L,CAP组VA的含量较对照组明显降低,且SCAP组明显低于MCAP组( <0.05)。根据WHO推荐的VA诊断标准,3组VA临床缺乏/亚临床缺乏率分别为10.00%、36.67%和61.90%,差异有统计学意义( <0.05)。CAP组血清中Ig水平较对照组明显降低,且SCAP组明显低于MCAP组( <0.05)。SCAP组血中总T淋巴细胞、CD4、CD8和CD4/CD8的平均水平分别为53.28%、30.26%、20.24%和1.59;分析VA水平与免疫相关指标关系发现VA水平与Ig(IgG、IgA、IgM)水平、总T淋巴细胞、CD4呈正相关,与CD8水平不相关。结论 肺炎患儿血清VA水平与病情严重程度及机体免疫功能相关。 相似文献
5.
Kyung-Suk Suh Suk Kyun Hong Sola Lee Su young Hong Sanggyun Suh Eui Soo Han Seong-Mi Yang YoungRok Choi Nam-Joon Yi Kwang-Woong Lee 《American journal of transplantation》2022,22(1):260-265
Minimally invasive approaches are increasingly being applied in surgeries and have recently been used in living donor hepatectomy. We have developed a safe and reproducible method for minimally invasive living donor liver transplantation, which consists of pure laparoscopic explant hepatectomy and pure laparoscopic implantation of the graft, which was inserted through a suprapubic incision. Pure laparoscopic explant hepatectomy without liver fragmentation was performed in a 60-year-old man with alcoholic liver cirrhosis and hepatocellular carcinoma. The explanted liver was retrieved through a suprapubic incision. A modified right liver graft, procured from his 24-year-old son using the pure laparoscopic method, was inserted through a suprapubic incision, and implantation was performed intracorporeally throughout the procedure. The time required to remove the liver was 369 min, and the total operative time was 960 min. No complications occurred during or after the surgery. The patient recovered well, and his hospital stay was of 11 days. Pure laparoscopic living donor liver transplantation from explant hepatectomy to implantation was performed successfully. It is a feasible procedure when performed by a highly experienced surgeon and transplantation team. Further studies with larger sample sizes are needed to confirm its safety and feasibility.
6.
7.
8.
9.
《Vaccine》2021,39(26):3459-3466
BackgroundSolid organ transplantation (SOT) candidates and recipients are highly vulnerable to invasive pneumococcal diseases (IPD). Data on which to base optimal immunization recommendations for this population is scant. The national distribution of IPD serotypes led the Swiss Health Authorities to recommend in 2014 one dose of pneumococcal-13-valent-conjugate-vaccine (PCV13), without any subsequent dose of the 23-valent-polysaccharide-pneumococcal-vaccine (PPV23).MethodsThis is a retrospective analysis of pneumococcal immunity using a multiplex binding assay, to assess seroprotection rates against a selection of seven PCV13- and seven PPV23-serotypes in SOT-candidates and recipients evaluated and/or transplanted in 2014/2015 in the University Hospitals of Geneva. Seroprotection was defined as serotype-specific antibody concentration greater than 0.5 mg/l and overall seroprotection when this was achieved for ≥ 6/7 serotypes.ResultsPre-vaccination and at time of transplant sera were available for 35/43 (81%), and 43/43 (100%) SOT-candidates respectively. At listing, 17/35 (49%) SOT-candidates were seroprotected against PCV13 and 21/35 (60%) against PPV23 serotypes. Following one systematic dose of PCV13 at listing, 35/43 (81%) SOT-recipients were seroprotected at day of transplant against PCV13-serotypes and 34/43 (79%) against PPV23 serotypes, compared to 21/41 (51%) and 28/41 (68%) respectively in the controls transplanted in 2013, before the systematic PCV13-vaccination.ConclusionsThe systematic vaccination with PCV13 of all SOT candidates without additional PPV23 is a good strategy as it confers seroprotection against a wide range of pneumococcal serotypes. Indeed, one of five PCV13-vaccinated SOT-candidates was nevertheless not seroprotected at time of transplant, reflecting their partial immune competence, and indicating the need for additional dose of pneumococcal vaccines before transplant. 相似文献
10.
乳腺癌已成为全球发病率最高的癌症,其异质性使得乳腺癌分类治疗进入了精准治疗时代。随着肿瘤免疫治疗的成功,既往被认为“弱免疫原性”的乳腺癌也跨入了免疫治疗阶段。目前,免疫检查点抑制剂在乳腺癌免疫治疗的临床应用中取得了重大进展,但乳腺癌免疫治疗单药的获益人群有限,联合方案成为新的研究热点。随着免疫检查点抑制剂在乳腺癌中的研究进展,有效联合免疫治疗和化疗可能提高乳腺癌病人的生存率,但用药时机和适用人群仍需合理评估。免疫治疗在乳腺癌中既有应用前景,也存在挑战。 相似文献